BIO 2026: CEO Calls for U.S. Biotech Urgency and International Competitiveness
SAN DIEGO — Biotechnology is entering one of the most transformative periods in its history. However, according to Biotechnology Innovation Organization (BIO) CEO John Crowley, outdated regulations, rising development costs, and global competition threaten to slow progress unless policymakers act swiftly. At the 2026 BIO International Convention in San Diego, which attracted approximately 20,000 attendees,…









